(OHRP) to Present at the 2014 Wedbush Life Sciences Management Access Conference

NEW YORK, Aug. 8, 2014  — Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that Sam Backenroth, Chief Financial Officer, will present a corporate overview and business update at the 2014 Wedbush Life Sciences Management Access Conference, being held at the Le Parker Meridien Hotel in New York City on August 12-13, 2014.

About Ohr Pharmaceutical, Inc.

Ohr Pharmaceutical, Inc. (OHRP) is an ophthalmology research and development company. The company’s lead product, Squalamine, is currently being studied as an eye drop formulation in several company sponsored and investigator sponsored Phase II clinical trials for various back-of-the-eye diseases, including the wet form of age-related macular degeneration, retinal vein occlusion, diabetic macular edema, and proliferative diabetic retinopathy. In addition, Ohr has a sustained release micro fabricated micro-particle ocular drug delivery platform with several preclinical drug product candidates in development for glaucoma, steroid-induced glaucoma, ocular allergies, and protein drug delivery. The lead sustained release program in glaucoma is proceeding under a collaboration with a large global pharmaceutical company. Additional information on the company may be found at www.ohrpharmaceutical.com.

CONTACT: Ohr Pharmaceutical Inc.
         Investor Relations
         888-388-2327
         ir@ohrpharmaceutical.com

         LifeSci Advisors, LLC
         Michael Rice
         646-597-6987
         mrice@lifesciadvisors.com

(MCRL) Honors The Memory Of Long-Time Board Member Michael Callahan

SAN JOSE, Calif., Aug. 8, 2014  — Micrel, Inc. (NASDAQ: MCRL), an industry leader in high-performance linear and power solutions, LAN and timing and communications solutions, announced that it is mourning the loss of board member Michael Callahan. Mr. Callahan passed away on August 5, 2014 after a lengthy illness.

“Micrel is mourning the passing of a dear friend and colleague,” noted Ray Zinn, President and CEO, Micrel. “Mike was not only a key board member at Micrel but he embodied the Micrel spirit in all that he did. As a former Marine, he generously volunteered his time to help veterans and was a role model and inspiration to us all; he will be sorely missed. He served as a member of Micrel’s Compensation and Audit Committees and helped to guide Micrel with his thoughtful, insightful experience. Our thoughts and prayers are with the entire Callahan family, particularly his children.”

Michael J. Callahan joined Micrel’s Board of Directors in May 2005. With more than 40 years of high tech experience, he served as Chairman of the Board of Directors, President and Chief Executive Officer of WaferScale Integration, Inc. and was President of Monolithic Memories, Inc. from 1978 to March 1990. During his tenure at Monolithic Memories, the company became a subsidiary of Advanced Micro Devices, Inc., where Mr. Callahan then served in the capacity of Senior Vice President of Programmable Products. Mr. Callahan earned a B.S.E.E. from the Massachusetts Institute of Technology.

About Micrel, Inc.
Micrel, Inc. is a leading global manufacturer of IC solutions for the worldwide high performance linear and power, LAN and timing and communications markets. The Company’s products include advanced mixed-signal, analog and power semiconductors; high performance communication, clock management, MEMs-based clock oscillators and crystal-less clock generators, Ethernet switch and physical layer transceiver ICs. Company customers include leading manufacturers of enterprise, consumer, industrial, mobile, telecommunications, automotive, and computer products. Corporation headquarters and state-of-the-art wafer fabrication facilities are located in San Jose, CA, with regional sales and support offices and advanced technology design centers situated throughout the Americas, Europe and Asia.  In addition, the Company maintains an extensive network of distributors and reps worldwide. Web: www.micrel.com.

(ICGE) Broadens Its Global EHS Footprint With Purchase of KMI

CHICAGO, Aug. 7, 2014  — In a move to accelerate growth and broaden its reach in the Environment, Health and Safety (EHS) market, MSDSonline – the leading provider of cloud-based compliance solutions – today announced it has acquired Oakville, Canada-based Knowledge Management Innovations (KMI), one of the most respected global EHS Management Information Systems (EMIS) providers. Under the agreement, KMI will be a wholly-owned subsidiary of MSDSonline. Terms of the agreement were not disclosed.

With a significant global user base, KMI is uniquely focused on end user adoption. The KMI software suite is designed to be easy to implement, intuitive to use and supports user self-training and rapid onboarding. The system allows companies to gain visibility throughout dispersed operations, control enterprise risk and improve performance through a comprehensive set of tools including incident management, audit, inspection, behavioral safety observation, compliance management, management of change, training tracking, risk analysis, performance metrics and corrective action management.

“We are excited to bring KMI’s deep domain expertise and broad suite of EHS products into our mix as they are the perfect complement to our core MSDS/chemical management solutions,” said Glenn Trout, President and CEO of MSDSonline. “This acquisition positions us well to extend our reach into the broader global EHS markets with robust offerings to help businesses of any size and in any industry manage the full spectrum of complex EHS regulatory issues.”

“We are thrilled to join forces with a powerhouse like MSDSonline,” said Matt Airhart, President and CEO of KMI. “With almost 10,000 customers, they have become one of the largest, most successful companies in the compliance software industry. We share the same customer-centric philosophy of bringing value, not just software features, to the marketplace. The software, service offerings and cultural fit of the two companies makes this a compelling merger. Together, we are going to set a new standard in EHS software and customer service excellence.”

About MSDSonlineFounded in 1996 and based in Chicago, MSDSonline is a leading provider of cloud-based EH&S compliance solutions, offering products and services for managing safety data sheets, reporting workplace incidents, training employees and administering other critical EH&S information. The company’s mission is to provide sustainable solutions that help customers improve employee safety, streamline compliance recordkeeping and reduce potential exposures to workplace hazards and risks. MSDSonline has been recognized for six years on Inc. magazine’s list of America’s 5,000 fastest-growing private companies. More information is available online at www.MSDSonline.com and on the official company blog at www.MSDSonline.com/blog. MSDSonline is an ICG (Nasdaq:ICGE) company.

About KMI

The KMI EHS Software Suite helps companies operate more sustainably, safely, and efficiently. By focusing on a rich and intuitive end user experience, KMI has developed an unparalleled record of user engagement and implementation success. KMI enables companies to reduce injuries, increase the effectiveness of regulatory compliance initiatives, perform audits and inspections, manage greenhouse gas reporting, and initiate or improve corporate sustainability programs. KMI is a trusted supplier of EHS Management Information Systems (EMIS) to global manufacturing, energy, mining, biotech, chemical, and transportation companies ranging in size from a few hundred to over half a million employees.

CONTACT: Media Contacts

         ICG
         Karen Green
         Karen@icg.com
         610.727.6858

         MSDSonline
         Brad Harbaugh
         bharbaugh@MSDSonline.com
         312.881.2855

         KMI
         James Haydock
         Jhaydock@kminnovations.com
         416.410.4817, ext. 2140

(ASYS) Announces Production Order for its IonSolar™ Implant System

TEMPE, Ariz.., Aug. 7, 2014  — Amtech Systems, Inc. (NASDAQ: ASYS), a global supplier of production and automation systems and related supplies for the manufacture of solar cells, semiconductors, and sapphire and silicon wafers, today announced its majority-owned subsidiary, Kingstone Semiconductor, has received an order for its IonSolar™ Implant system from a Chinese solar company.  The implant system will be used in a high throughput production environment for high efficiency solar cells.  The order is expected to ship in the next six months.

Mr. Fokko Pentinga, Chief Executive Officer of Amtech, commented, “We are very pleased to announce this new order for our IonSolar™ Implant system.  Much progress has been made expanding our market opportunities and technology offerings.  In addition to this new ion implant production order, we shipped our new PECVD system to a highly respected Korean customer, our new high density, high throughput diffusion system to a key customer in Taiwan, and the ion implant system, which shipped in April to the Energy Research Centre of The Netherlands, has been installed.  We have also made excellent progress on our n-type cell line with our US customer in San Antonio, Texas. We believe there is increasing momentum in the marketplace to invest in next generation technology solutions to improve the conversion efficiency of solar cells and lower the total cost of ownership. We continue to prudently invest in the development of next generation solutions and are engaged in discussions with current and prospective customers regarding their specific technology objectives and future capacity requirements for 2015 and beyond.”

About Amtech Systems, Inc.

Amtech Systems, Inc. manufactures capital equipment, including silicon wafer handling automation, thermal processing and ion implant equipment and related consumables used in fabricating solar cells, LED and semiconductor devices. Semiconductors, or semiconductor chips, are fabricated on silicon wafer substrates, sliced from ingots, and are part of the circuitry, or electronic components, of many products including solar cells, computers, telecommunications devices, automotive products, consumer goods, and industrial automation and control systems. The Company’s wafer handling, thermal processing and consumable products currently address the diffusion, oxidation, and deposition steps used in the fabrication of solar cells, LEDs, semiconductors, MEMS and the polishing of newly sliced silicon wafers.

Cautionary Note Regarding Forward-Looking Statements

Certain information contained in this press release is forward-looking in nature. All statements in this press release, or made by management of Amtech Systems, Inc. and its subsidiaries (“the Company” or “Amtech”), other than statements of historical fact, are hereby identified as “forward-looking statements” (as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “would,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology.  Examples of forward-looking statements include statements regarding Amtech’s future financial results, operating results, business strategies, projected costs, products under development, competitive positions and plans and objectives of the Company and its management for future operations.

We cannot guarantee that any forward-looking statement will be realized, although we believe that the expectations reflected in the forward-looking statements are reasonable. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. The Form 10-K that we filed with the Securities and Exchange Commission for the year-ended September 30, 2013 listed various important factors that could affect Amtech’s future operating results and financial condition and could cause actual results to differ materially from historical results and expectations based on forward-looking statements made in this document or elsewhere by Amtech or on its behalf.  These factors can be found under the heading “Risk Factors” in the Form 10-K and investors should refer to them.  Because it is not possible to predict or identify all such factors, any such list cannot be considered a complete set of all potential risks or uncertainties.  Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:

(SPWH) and Alaska Wildfowl Adventures Announce 4-Day Sea Duck Hunt Giveaway

MIDVALE, Utah, Aug. 7, 2014 — Sportsman’s Warehouse (Nasdaq:SPWH) is teaming up with Alaska Wildfowl Adventures to offer one lucky winner the opportunity to experience a 4-day sea duck hunt this fall. Applicants will be required to submit an official web entry form along with an essay about “Why I am Passionate about Hunting.” Official rules and the web entry from can be found by visiting www.sportsmanswarehouse.com during the contest period which ends September 10^th.

The 4-day hunt will take place in Valdez, Alaska and be guided by Alaska Wildfowl Adventures. In addition to the hunt, the prize will include a Browning Maxus 12 gauge shotgun,  a pair of Vortex binoculars, and a Benchmade knife.  The total prize package has a retail value of $5,000.00.

The hunt will be videotaped as a potential episode on Alaska Outdoor Television as well as for use by Sportsman’s Warehouse. “This is a rare opportunity for someone who loves to hunt, especially waterfowl, to hunt sea ducks in Valdez, Alaska,” states Tim Delarm, Owner of Alaska Outdoor Television. “We are pleased to offer one of our customers this great hunt and wonderful prizes from Browning, Vortex and Benchmade. So whoever wins this great prize will be one very happy hunter,” says Karen Seaman, Chief Marketing Officer, Sportsman’s Warehouse.

Sportsman’s Warehouse serves outdoor enthusiasts, casual users and first time participants with quality brand-name hunting, fishing, camping and shooting merchandise within a convenient shopping environment, serviced by passionate, knowledgeable associates to create a memorable outdoor experience. To find the Sportsman’s Warehouse nearest you or to shop online, visit us on the Web at www.sportsmanswarehouse.com.

CONTACT: Karen Seaman, Chief Marketing Officer
         Sportsman's Warehouse Corporate Office
         kseaman@sportsmanswarehouse.com

(CARO) Expands In South Carolina, North Carolina With 13 Branch Purchase

CHARLESTON, S.C., Aug. 7, 2014  — CresCom Bank, the wholly-owned bank subsidiary of Carolina Financial Corporation (NASDAQ: CARO), today announced it has entered into a definitive agreement with First Community Bank, Bluefield, Virginia to acquire 13 branches with total deposits of approximately $230 million and approximately $59 million in loans.  Three of the offices are in South Carolina and operate under the name “People’s Community Bank” and 10 are in southeastern North Carolina.  The deposit premium will be approximately 3.11% of deposits acquired.  Upon completion of the purchase, CresCom Bank will have 27 branch locations, including two new offices planned to open later this summer in Cane Bay and Socastee, S.C.

Upon completion of the transaction, CresCom Bank is expected to have approximately $1.2 billion in assets, $0.7 billion in loans, and $1.0 billion in deposits. The transaction is expected to be immediately accretive to Carolina Financial Corporation’s fully diluted earnings per share, excluding one-time deal costs.

The transaction, which is subject to regulatory approval and other customary conditions, is expected to close in late 2014 or early 2015. The terms of the agreement have been approved by the Board of Directors of both companies.

“Our acquisition of these 13 branches dramatically increases our footprint throughout the coastal region of the Carolinas,” said Carolina Financial Corporation President and CEO Jerry Rexroad. “This is a reflection of the accretive growth our board of directors and leadership team have been striving toward. These branches are in key markets and Coastal regions very similar to our current markets, which will help us continue to deliver quality products and services to customers.”

An investor presentation accompanies this press release.

For more information about investor relations, contact Carolina Financial Corporation EVP and CFO Bill Gehman, bgehman@haveanicebank.com, (843) 534-5120.

About Carolina Financial Corporation
Carolina Financial Corporation (NASDAQ: CARO) is the holding company of CresCom Bank, which also owns and operates Atlanta-based Crescent Mortgage Company.  As of June 30, 2014, Carolina Financial Corporation had $988 million in total assets, CresCom Bank operated 12 branch locations in the Charleston and Myrtle Beach areas of South Carolina, and Crescent Mortgage Company originated loans in 48 states and partnered with approximately 2,000 community banks, credit unions and mortgage brokers, offering access to various loan programs.  CresCom Bank offers a strong core of banking products and services.  To learn more about CresCom Bank, visit www.facebook.com/CresComBank and www.twitter.com/CresComBank or call 1-855-CRESCOM.

Forward-Looking Statements

Certain statements in this news release contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future plans and expectations, and are thus prospective.  Such forward-looking statements include but are not limited to statements with respect to our plans, objectives, expectations and intentions and other statements that are not historical facts, and other statements identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “targets,” and “projects,” as well as similar expressions. Such statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements.  Although we believe that the assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove to be inaccurate. Therefore, we can give no assurance that the results contemplated in the forward-looking statements will be realized. The inclusion of this forward-looking information should not be construed as a representation by Carolina Financial Corporation or any person that such future events, plans, or expectations will occur or be achieved.  In addition to factors previously disclosed in the registration statement and reports filed by Carolina Financial Corporation with the Securities and Exchange Commission, additional risks and uncertainties may include, but are not limited to: the possibility that any of the anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period; the risk that integration of operations with those of Carolina Financial Corporation will be materially delayed or will be more costly or difficult than expected; the failure to satisfy other conditions to completion of the transaction, including receipt of required regulatory and other approvals; the failure of the proposed transaction on customer relationships and operating results; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; and general competitive, economic, political and market conditions and fluctuations.

Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found in the registration statement and reports (such as our Registration Statement on Form 10, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K) filed with the SEC and available at the SEC’s Internet site (http://www.sec.gov). All subsequent written and oral forward-looking statements concerning the company or any person acting on its behalf is expressly qualified in its entirety by the cautionary statements above. We do not undertake any obligation to update any forward-looking statement to reflect circumstances or events that occur after the date the forward-looking statements are made.

(DXCM) Data Integration Relationship with Asante Solutions

Asante Solutions, Inc., manufacturer of the Asante Snap Insulin Pump, and DexCom, Inc. (NASDAQ: DXCM) announced today their intention to enable the Dexcom mobile app platform, which is currently under development, to integrate and display insulin data from the Asante Snap Insulin Pump. This will be the second insulin delivery device to be integrated into the Dexcom mobile app, which is designed to aggregate glucose and other diabetes-related data from patients’ devices and display the integrated data on a smartphone. In June, Dexcom announced its intention to maintain an “open architecture” approach to diabetes-related data which will include an “Authorized by Dexcom” mark to indicate the compatibility of devices and apps integrating Dexcom CGM data.

“Asante’s mission is to simplify the management of diabetes, both for people with diabetes and their healthcare providers, and this is the next step in doing so,” said David Thrower, CEO of Asante Solutions. Integration with the Dexcom mobile platform is the next step in our commitment to make pump data available where and how a patient will want to view it,” Thrower continued.

“More than ever, we believe that effective diabetes management depends on timely and accurate data. That is why we are excited to complete development of our mobile app and integrate data from the Asante Snap™ Insulin Pump system,” said Kevin Sayer, Dexcom President and Chief Operating Officer.

About Asante Solutions, Inc.

Based in the heart of Silicon Valley, Asante Solutions, Inc. is a privately-held diabetes company. Asante was founded on a belief that life could be made simpler for people with diabetes, and those who love them. For more information, visit www.snappump.com.

About DexCom, Inc.

DexCom, Inc. (www.dexcom.com), headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Dexcom Cautionary Statement Regarding Forward Looking Statements

Dexcom is a medical device company with a limited operating history. Successful commercialization of the company’s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company’s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company’s quarterly report on Form 10-Q for the period ending June 30, 2014, as filed with the Securities and Exchange Commission on August 6, 2014.

(VGGL) Records Best Month to Date

Viggle Inc. (NASDAQ:VGGL) (“Viggle”), the entertainment marketing and rewards platform, today released user data showing July 2014 as the best month in the company’s history, in terms of adding new registered users and driving monthly active users on the Viggle Platform.

The figures show about 860,000 monthly active users and an increase of approximately 566,000 new registered users.

Viggle Inc. has seen increasing cross-platform adoption of users of its various web, social and mobile properties which has boosted both key performance indicators. Viggle first announced the expansion of its platform integration — which allows point earning on the web – on June 2. That enabled users at Wetpaint, the leading digital destination and social publisher for entertainment fans, to earn Viggle Points for watching original video content.

Viggle and Wetpaint enhanced the consumer proposition on July 24 with the introduction of the Wetpaint VIP program. Wetpaint VIP membership ties Wetpaint users into the Viggle Platform and provides access to exclusive content and discounted rewards, plus automatic entry into sweepstakes.

The introduction of point-earning opportunities and the VIP program have dramatically increased the number of registrations for the Viggle Platform from Wetpaint’s millions of monthly unique visitors. In addition to the rapid registration growth, Viggle and Wetpaint are also seeing a marked increase in the number of original videos users are watching to earn Viggle Points they can redeem for rewards like song downloads, gift cards, electronics, and more.

“The early results of bringing our points earning and entertainment rewards model to web content are very encouraging,” said Greg Consiglio, President and Chief Operating Officer of Viggle. “Each month, Wetpaint reaches a highly social audience of TV fans who are now more engaged than ever. This is just the very successful beginning of expanding our entertainment and brand engagement rewards solutions to wherever fans are watching their favorite content.”

Viggle Inc.’s platform consists of the Viggle app, which offers rewards for watching TV, advertisements or listening to music; NextGuide, a personalized TV programming guide and distributed reminder platform; Wetpaint, an entertainment news and social publishing platform; and Viggle Store, a rewards destination where visitors can redeem Viggle Points for digital downloads. In June 2014, Viggle Inc. achieved a total reach of 18.4 million. Total reach is the total of registered users for the Viggle app and monthly unique users of the Wetpaint media properties.

About Viggle

Viggle is an entertainment marketing and rewards platform whose app rewards its members for watching TV shows and discovering new music. The Viggle mobile app has over 6.2 million users. Since its launch, Viggle members have redeemed nearly $19 million in rewards for watching their favorite TV programs and listening to music. Members can also use Viggle Store, a rewards destination where they can redeem their Viggle Points for music downloads. In addition, Viggle operates Wetpaint, which offers entertainment and celebrity news online; Dijit Media, maker of technology that helps consumers search for, find, and set reminders for TV shows and movies; and Choose Digital, a digital marketplace platform that allows companies to incorporate digital content into existing rewards and loyalty programs in support of marketing and sales initiatives. For more information, visit www.viggle.com or follow us on Twitter @Viggle.

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. All information provided in this press release is as of the date of this release. Except as required by law, Viggle Inc. undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

(EBIX) Announces a New $150,000,000 Syndicated Senior Secured Credit Facility

ATLANTA, Aug. 6, 2014  — Ebix, Inc. (Nasdaq:EBIX) a leading provider of On-Demand software and E-commerce services to the insurance and financial industries, today announced that it has closed on a $150,000,000 credit line as of August 5, 2014, to fund its growth and share repurchase initiatives. The Company signed the credit line with a syndicate of leading financial institutions that include Regions Bank, MUFG Union Bank, N.A., and Silicon Valley Bank, with Regions Bank as administrative agent and collateral agent. Regions Capital Markets, a division of Regions Bank, and MUFG Union Bank served as Joint Lead Arrangers on the transaction.

The Company put the credit facility in place to fund its future acquisition and share repurchase initiatives, as also to provide increased working capital to fund its growth initiatives. The credit line provides the Company with an expanded and flexible credit line, at lower rates than the present credit facility.

Robin Raina, President & CEO, Ebix Inc. said, “We are excited to have the support of leading financial institutions like Regions Bank, MUFG Union Bank, and Silicon Valley Bank, towards funding our future growth and share repurchase initiatives. Their faith in us is a testament to the strength of the fundamentals of Ebix, and I thank them for working with us to create a flexible expanded credit line at competitive affordable rates.”

The new credit facility has the following key components –

• A five year revolving credit facility for $150,000,000
• Ebix has the option to request an increase in the Credit Facilities of up to $200,000,000, without Lender approval, subject to receipt of additional lender commitments

The credit facility will bear an interest rate at closing equal to LIBOR plus a LIBOR margin of 1.75%. As of January 1, 2015, the LIBOR margin will be based on a leveraged-based pricing grid. Based on Ebix’s estimates, the leveraged-based pricing grid would have resulted in a LIBOR margin of 1.50% as of closing.

The Company also announced that it now has access to total funds of approximately $150,000,000 to fund any of its working capital or any other growth and share repurchase initiatives. This includes the worldwide cash balances in the bank of approximately $ 33,000,000 in addition to available credit line of approximately $117,000,000 million after paying off the previous credit line of approximately $33,000,000.

About Regions Financial Corporation

Regions Financial Corporation (NYSE:RF), with $119 billion in assets, is a member of the S&P 500 Index and is one of the nation’s largest full-service providers of consumer and commercial banking, wealth management, mortgage, and insurance products and services. Regions serves customers in 16 states across the South, Midwest and Texas, and through its subsidiary, Regions Bank, operates approximately 1,700 banking offices and 2,000 ATMs. Investment banking and business advisory services are offered through Regions Securities LLC. Member FINRA & SIPC. Additional information about Regions and its full line of products and services can be found at www.regions.com.

About MUFG Union Bank, N.A.

MUFG Union Bank, N.A., is a full-service bank with offices across the United States. We provide a wide spectrum of corporate, commercial, retail banking and wealth management solutions to meet the needs of customers.  The bank also offers an extensive portfolio of value-added solutions for customers, including investment banking, personal trust, capital markets, global treasury management, transaction banking and other services. With assets of $108.8 billion (USD), as of June 30, 2014, the bank has strong capital reserves, credit ratings and capital ratios relative to peer banks. MUFG Union Bank is a proud member of the Mitsubishi UFJ Financial Group (NYSE:MTU), one of the world’s largest financial organizations with total assets of approximately ¥258 trillion (JPY) or $2.5 trillion (USD)¹, as of March 31, 2014. MUFG Americas Holdings Corporation, the financial holding company and MUFG Union Bank, N.A. have corporate headquarters in New York City.

¹ Exchange rate of USD=¥102.92 (J-GAAP) as of March 31, 2014

About Ebix, Inc.

A leading international supplier of On-Demand software and E-commerce services to the insurance industry, Ebix, Inc., (Nasdaq:EBIX) provides end-to-end solutions ranging from infrastructure exchanges, carrier systems, agency systems and risk compliance solutions to custom software development for all entities involved in the insurance industry.

With 35+ offices across Australia, Brazil, Canada, India, New Zealand, Singapore, the US and the UK, Ebix powers multiple exchanges across the world in the field of life, annuity, health and property & casualty insurance while conducting in excess of $100 billion in insurance premiums on its platforms. Through its various SaaS-based software platforms, Ebix employs hundreds of insurance and technology professionals to provide products, support and consultancy to thousands of customers on six continents. For more information, visit the Company’s website at www.ebix.com

SAFE HARBOR REGARDING FORWARD-LOOKING STATEMENTS

As used herein, the terms “Ebix,” “the Company,” “we,” “our” and “us” refer to Ebix, Inc., a Delaware corporation, and its consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only Ebix, Inc.

The information contained in this Press Release contains forward-looking statements and information within the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. This information includes assumptions made by, and information currently available to management, including statements regarding future economic performance and financial condition, liquidity and capital resources, acceptance of the Company’s products by the market, and management’s plans and objectives. In addition, certain statements included in this and our future filings with the Securities and Exchange Commission (“SEC”), in press releases, and in oral and written statements made by us or with our approval, which are not statements of historical fact, are forward-looking statements. Words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “seeks,” “plan,” “project,” “continue,” “predict,” “will,” “should,” and other words or expressions of similar meaning are intended by the Company to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are found at various places throughout this report and in the documents incorporated herein by reference. These statements are based on our current expectations about future events or results and information that is currently available to us, involve assumptions, risks, and uncertainties, and speak only as of the date on which such statements are made.

Our actual results may differ materially from those expressed or implied in these forward-looking statements. Factors that may cause such a difference, include, but are not limited to those discussed in our Annual Report on Form 10-K and subsequent reports filed with the SEC, as well as: the risk of an unfavorable outcome of the pending governmental investigations or shareholder class action lawsuits, reputational harm caused by such investigations and lawsuits, the willingness of independent insurance agencies to outsource their computer and other processing needs to third parties; pricing and other competitive pressures and the Company’s ability to gain or maintain share of sales as a result of actions by competitors and others; changes in estimates in critical accounting judgments; changes in or failure to comply with laws and regulations, including accounting standards, taxation requirements (including tax rate changes, new tax laws and revised tax interpretations) in domestic or foreign jurisdictions; exchange rate fluctuations and other risks associated with investments and operations in foreign countries (particularly in Australia and India wherein we have significant operations); equity markets, including market disruptions and significant interest rate fluctuations, which may impede our access to, or increase the cost of, external financing; and international conflict, including terrorist acts.

Except as expressly required by the federal securities laws, the Company undertakes no obligation to update any such factors, or to publicly announce the results of, or changes to any of the forward-looking statements contained herein to reflect future events, developments, changed circumstances, or for any other reason.

Readers should carefully review the disclosures and the risk factors described in the documents we file from time to time with the SEC, including future reports on Forms 10-Q and 8-K, and any amendments thereto.

You may obtain our SEC filings at our website, www.ebix.com under the “Investor Information” section, or over the Internet at the SEC’s web site, www.sec.gov.

CONTACT: Investors
         Aaron Tikkoo
         678-281-2027 or atikkoo@ebix.com

(BPHX) and ATERAS Merge to Create ‘Modern Systems’

Strategic Combination Creates One of the Largest Legacy Modernization Companies in the World

(ITRI) to Present at the 34th Annual Canaccord Genuity Growth Conference

Itron, Inc. (NASDAQ: ITRI) announced today that Philip Mezey, Itron’s president and chief executive officer, will present at the 34^th Annual Canaccord Genuity Growth Conference at the InterContinental Hotel in Boston. The company’s investor presentation will be webcast live on Thursday, Aug.14, 2014 at 9 a.m. EDT / 6 a.m. PDT.

The live audio webcast and investor presentation will be accessible via Itron’s Investor Relations website at http://investors.itron.com/events.cfm. A replay of the webcast will be available for 30 days following the event.

About Itron

Itron is a world-leading technology and services company dedicated to the resourceful use of energy and water. We provide comprehensive solutions that measure, manage and analyze energy and water. Our broad product portfolio includes electricity, gas, water and thermal energy measurement devices and control technology; communications systems; software; as well as managed and consulting services. With thousands of employees supporting nearly 8,000 customers in more than 100 countries, Itron applies knowledge and technology to better manage energy and water resources. Together, we can create a more resourceful world. Join us: www.itron.com.

Forward-Looking Statements

During the course of the presentation, Itron may make forward-looking statements regarding future events or the future financial performance of the company. These statements reflect our current plans and expectations and are based on information currently available. The statements rely on a number of assumptions and estimates, which could be inaccurate, and which are subject to risks and uncertainties that could cause our actual results to vary materially from those anticipated. Risks and uncertainties are more fully described in our Annual Report on Form 10-K for the year ended December 31, 2013 and other reports on file with the Securities and Exchange Commission. Itron undertakes no obligation to update publicly or revise any forward-looking statements, including our business outlook.

(EGLE) Agreement With Lenders To Significantly Reduce Debt, Strengthen Balance Sheet

— Company Executes Restructuring Support Agreement and Files Prepackaged Plan of Reorganization for Parent with Overwhelming Lender Support — — Operating and Management Subsidiaries Excluded from Filing; All Business Activities Continue in the Normal Course — — Plan Expected to Reduce Total Debt by Approximately $975 Million and Provides Payment in Full for Trade Creditors — — Company Secures up to $50M in DIP Financing —

NEW YORK, Aug. 6, 2014  — Eagle Bulk Shipping Inc. (Nasdaq: EGLE) (“Eagle Bulk” or “the Company”) today announced that it has entered into a Restructuring Support Agreement (“RSA”) with lenders (the “Lenders”) holding more than 85% of the loans outstanding under its Fourth Amended and Restated Credit Agreement, dated June 20, 2012 (the “Credit Agreement”), regarding the terms of a balance sheet restructuring that will strengthen Eagle Bulk’s financial position, reduce its debt obligations by approximately $975 million, and significantly enhance liquidity.

To implement the restructuring, Eagle Bulk, the parent company, has commenced a voluntary “prepackaged” chapter 11 case in the United States Bankruptcy Court for the Southern District of New York (the “Court”). The prepackaged case, which excludes all of the Company’s operating and management subsidiaries, is intended to facilitate a prompt exit from the financial restructuring process without disruption to Eagle Bulk’s business.

In conjunction with the prepackaged case, Eagle Bulk also filed its proposed plan of reorganization (the “Plan”) and related disclosure statement. The Company has already received affirmative votes for the Plan from Lenders holding more than 85% of the loans outstanding under its Credit Agreement, constituting more than two-thirds of the total Lenders thereunder, amounts sufficient under applicable law for the Court to confirm the Plan.

Eagle Bulk has also obtained a commitment for up to $50 million of debtor-in-possession (“DIP”) financing from certain of its Lenders which, subject to Court approval, will significantly enhance liquidity.

During the process, Eagle Bulk intends to continue normal day-to-day operations, including:

• Honoring all customer arrangements in the ordinary course of business;
• Payment of amounts owed to the Company’s vendors, suppliers, and business partners; and,
• Uninterrupted payment of wages, salaries, and other compensation to the Company’s crew, employees, and independent contractors.

Eagle Bulk’s management will remain in place and Sophocles N. Zoullas will remain Chairman and Chief Executive Officer of the reorganized Eagle Bulk.

“With an expedited restructuring process now underway, we are pleased to have the ongoing support of our Lenders, with whom we will work in partnership to recapitalize Eagle Bulk’s balance sheet and significantly reduce the Company’s debt load,” Mr. Zoullas commented. “We continue to benefit from a world-class, highly-efficient and versatile fleet, and a deep and experienced management team. Upon emergence from the process, we will continue to build on these competitive advantages and further grow our leadership position in the dry bulk market.  We are grateful for the strong support from our Lenders, and look forward to the emergence of an Eagle Bulk that is well-positioned for many years of success.”

Mr. Zoullas concluded, “We expect our business activities to continue in the normal course during the restructuring process. The Company’s reputation has been built on superior industry relationships and operational excellence – attributes that we will build on moving forward.”

Under the terms of the Plan, the Lenders will convert their debt into 99.5% of the new equity in the reorganized Eagle Bulk, subject to dilution, and receive a cash distribution from the proceeds of an exit financing facility. All existing equity interests in Eagle Bulk will be cancelled, with such equity interests receiving, subject to dilution, 0.5% of the new equity in the reorganized Eagle Bulk and seven-year warrants to acquire an additional 7.5% of the new equity in the reorganized Eagle Bulk.

To further ensure that its suppliers, chartering counterparties, business partners, crew members, and employees are unaffected by the restructuring process, Eagle Bulk is seeking customary “first day” motions with the Court to authorize continued payments in the ordinary course of business.

Court documents and other information for the Company’s stakeholders are available on a dedicated website administered by Eagle Bulk’s noticing agent, Kurtzman Carson Consultants, at www.eaglebulkrestructuring.com, or by calling 877-709-4746 (424-236-7227 for international calls). Inquiries may also be emailed to: eaglebulkinfo@kccllc.com.

Eagle Bulk’s legal advisor is Milbank, Tweed, Hadley & McCloy LLP, its financial advisor is Moelis & Company, and its restructuring advisor is Alvarez & Marsal.

About Eagle Bulk Shipping Inc.

Eagle Bulk Shipping Inc. is a Marshall Islands corporation headquartered in New York. The Company is a leading global owner of Supramax dry bulk vessels that range in size from 50,000 to 60,000 deadweight tons and transport a broad range of major and minor bulk cargoes, including iron ore, coal, grain, cement and fertilizer, along worldwide shipping routes.

Forward-Looking Statements

This press release contains forward-looking statements.  These forward‑looking statements are based on the current expectations and observations of the Company’s management, and include factors that could cause actual results to differ materially, such as:  the Company’s ability to meet current operating needs, including its ability to maintain contracts that are critical to its operation, to obtain and maintain acceptable terms with its vendors, customers, and service providers and to retain key executives, managers, and employees; the Company’s ability to obtain Court approval with respect to motions in the prepackaged case; the effects of the Court rulings in the prepackaged case and the outcome of the case in general; the length of time the Company will operate under the prepackaged case; the pursuit by the Company’s various creditors, equity holders, and other constituents of their interests in the prepackaged case; risks associated with third party motions in the prepackaged case, which may interfere with the ability to consummate the Plan; the adverse effects of the prepackaged case on the Company’s liquidity or results of operations generally; the increased administrative and restructuring costs related to the prepackaged case; the Company’s ability to maintain adequate liquidity to fund operations during the prepackaged case and thereafter; the sufficiency of the “exit” financing contemplated by the Plan; the Company’s ability in the future to arrange and consummate financing or sale transactions or to access capital; the effects of changes in the Company’s credit ratings; the timing and realization of the recoveries of assets and the payments of claims in the prepackaged case and the amount of expenses projected to recognize such recoveries and reconcile such claims; the occurrence of any event, change, or other circumstance that could give rise to the termination of the RSA; the effects of actions taken by NASDAQ against the Company during the pendency of the restructuring, including the possibility of delisting; and the other factors listed from time to time in the Company’s filings with the SEC, including, without limitation, its Annual Report on Form 10-K for the year ended December 31, 2013 and subsequent filings on Form 10-Q and Form 8-K.

Nothing in this press release shall constitute a solicitation of any holders of any of our indebtedness or our securities with respect to the matters contemplated in the RSA or an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities of the Company.

(ETRM) to Participate in Canaccord Genuity 34th Annual Growth Conference

ST. PAUL, Minn., Aug. 6, 2014  — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, PhD., EnteroMedics’ President and Chief Executive Officer is scheduled to participate in the Canaccord Genuity 34^th Annual Growth Conference.  The event will be held on August 14, 2014 at 11:30 am Eastern Time at the InterContinental Hotel, Boston, MA.

Dr. Knudson will provide an overview of EnteroMedics and its development and commercialization program for VBLOC® vagal blocking therapy.

The presentation will be webcast live and may be accessed by visiting EnteroMedics’ website at www.enteromedics.com. A replay of the webcast will also be available immediately after the conclusion of the presentation for a period of ninety days. Investors can access the webcast under “Events” in the “Investors” section of EnteroMedics’ website.

Institutional investors who wish to request a meeting with EnteroMedics should contact Canaccord Genuity.

About EnteroMedics Inc.

EnteroMedics is a medical device company focused on the development and commercialization of its neuroscience based technology to treat obesity and metabolic diseases. VBLOC® vagal blocking therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses, which helps control both hunger and fullness. VBLOC allows people with obesity to take a positive path towards weight loss, addressing the lifelong challenge of obesity and its comorbidities without sacrificing wellbeing or comfort.  EnteroMedics’ Maestro Rechargeable System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.

Forward-Looking Safe Harbor Statement

This press release contains forward-looking statements about EnteroMedics Inc. Our actual results could differ materially from those discussed due to known and unknown risks, uncertainties and other factors including our limited history of operations; our losses since inception and for the foreseeable future; our lack of commercial regulatory approval for our Maestro® System for the treatment of obesity in the United States or in any foreign market other than Australia and the European Community; our preliminary findings from our EMPOWER™ and ReCharge pivotal trials; our ability to comply with the Nasdaq continued listing requirements; our ability to commercialize our Maestro System; our dependence on third parties to initiate and perform our clinical trials; the need to obtain regulatory approval for any modifications to our Maestro System; physician adoption of our Maestro System and VBLOC® vagal blocking therapy; our ability to obtain third party coding, coverage or payment levels; ongoing regulatory compliance; our dependence on third party manufacturers and suppliers; the successful development of our sales and marketing capabilities; our ability to raise additional capital when needed; international commercialization and operation; our ability to attract and retain management and other personnel and to manage our growth effectively; potential product liability claims; potential healthcare fraud and abuse claims; healthcare legislative reform; and our ability to obtain and maintain intellectual property protection for our technology and products. These and additional risks and uncertainties are described more fully in the Company’s filings with the Securities and Exchange Commission, particularly those factors identified as “risk factors” in the annual report on Form 10-K filed March 27, 2014. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Caution – Investigational device. Limited by Federal (United States) law to investigational use.

The implantation procedure and usage of the Maestro® System carry some risks, such as the risks generally associated with laparoscopic procedures and those related to treatment as described in the ReCharge clinical study informed consent.

(MNDO) Reports New Record Quarterly Revenues of $6.3 Million

(WHLM) Announces Uplisting to the NASDAQ Capital Market

DALLAS, Aug. 5, 2014  — Wilhelmina International, Inc. (OTCBB:WHLM) (the “Company”) announced today that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market. Effective Tuesday, August 5, 2014, the stock will trade on NASDAQ under the ticker WHLM.

“We are pleased to be bringing Wilhelmina’s common stock to NASDAQ. While Wilhelmina has long been recognized as a leader within the modeling and fashion industries, the uplisting of the common stock to a national exchange should begin to enhance the awareness of the Company in the capital and consumer markets. As one of the largest and most successful model talent agencies in the world, with almost 50 years of experience, and the only publicly traded modeling agency in North America, a national listing on the NASDAQ Capital Market is a great venue for Wilhelmina,” commented Mark Schwarz, Executive Chairman of Wilhelmina.

Wilhelmina’s common shares will trade under the ticker symbol “WHLM” when trading on Nasdaq begins Tuesday, August 5, 2014.

About Wilhelmina International, Inc. (www.wilhelmina.com):

Through Wilhelmina Models and its other subsidiaries, including, Wilhelmina Artist Management, Wilhelmina International, Inc. provides traditional, full-service fashion model and talent management services, specializing in the representation and management of leading models, entertainers, artists, athletes and other talent to various customers and clients, including, retailers, designers, advertising agencies and catalog companies. Wilhelmina Models was founded in 1967 by Wilhelmina Cooper, a renowned fashion model, and is one of the oldest and largest fashion model management companies in the world. Wilhelmina Models is headquartered in New York and, since its founding, has grown to include operations located in Los Angeles and Miami, as well as a growing network of licensees comprising leading modeling agencies in various local markets across the U.S.as well as in Thailand, Dubai, Vancouver and Tokyo.

Forward-Looking Statements

This report contains certain “forward-looking” statements as such term is defined in the Private Securities Litigation Reform Act of 1995 and information relating to the Company and its subsidiaries that are based on the beliefs of the Company’s management as well as assumptions made by and information currently available to the Company’s management. When used in this report, the words “anticipate”, “believe”, “estimate”, “expect” and “intend” and words or phrases of similar import, as they relate to the Company or its subsidiaries or Company management, are intended to identify forward-looking statements. Such statements reflect the current risks, uncertainties and assumptions related to certain factors including, without limitation, competitive factors, general economic conditions, the interest rate environment, governmental regulation and supervision, seasonality, changes in industry practices, one-time events and other factors described herein and in other filings made by the Company with the SEC. Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. The Company does not intend to update these forward-looking statements.

CONTACT: John Murray
         Chief Financial Officer
         Wilhelmina International, Inc.
         214-661-7480
         john@wilhelmina.com

         Website: http://www.wilhelmina.com

(AGTC) to Present at Upcoming Investor Conferences

GAINESVILLE, Fla., Aug. 5, 2014  — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced that company management will participate in upcoming investor conferences.

• Piper Jaffray Heartland Summit on Thursday, August 7^th, 2014 in Minneapolis. Sue Washer, President and CEO will participate in a panel discussing advances in gene therapy.
• Wedbush Securities Life Sciences Management Access Conference on Wednesday, August 13^th, 2014 at 1:20pm ET in New York. Ms. Washer will provide a corporate overview discussing the company’s lead programs in ophthalmology, including X-linked Retinoschisis (XLRS), Achromatopsia (ACHM) and X-linked Retinitis Pigmentosa (XLRP). To access a live webcast of this presentation, please visit http://ir.agtc.com/. A replay will be available for two weeks following the presentation.

About AGTC

AGTC is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases in ophthalmology AGTC’s lead product candidates, which are each in the preclinical stage, focus on X-linked retinoschisis, achromatopsia and X-linked retinitis pigmentosa, which are inherited orphan diseases of the eye, caused by mutations in single genes, that significantly affect visual function and currently lack effective medical treatments. AGTC has recently begun development of a product to treat Wet AMD using the companies experience in ophthalmology to expand into disease indications with larger markets.

Forward Looking Statements

Statements in this press release regarding Applied Genetics Technology Corporation that do not relate to historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, information concerning possible or assumed future results of operations, business strategies and operations, preclinical and clinical product development and regulatory progress, financing plans, potential growth opportunities, potential market opportunities and the effects of competition, and can be identified by terms such as “anticipates,” “believes,” “could,” “seeks,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions and the negatives of those terms. Readers are cautioned that these forward-looking statements are subject to risks and uncertainties and are only predictions, and actual future events and results may differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those risks and uncertainties that are discussed under “Risk Factors” in our registration statement on Form S-1 (File No. 333-193309), as amended, and our periodic and current reports filed with the SEC.  Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent management’s plans, estimates, assumptions and beliefs only as of the date of this release. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

CONTACT: David Carey
         Lazar Partners Ltd.
         T: (212) 867-1768
         dcarey@lazarpartners.com

         Corporate Contact:
         Larry Bullock
         Chief Financial Officer
         Applied Genetic Technologies Corporation
         T: (386) 462-2204
         lbullock@agtc.com

(ISR) Cesium-131 Isotope Excellent Results in Treating Metastatic Brain Cancer

100% Local (Resection Cavity) Freedom From Progression With 19.3 Month Median Follow-Up

(CRRS) Promotes Adrian Hobbs to Spearhead European Business

Corporate Resource Services, Inc. (NASDAQ:CRRS), a diversified technology, staffing, recruiting, and consulting services firm, today reported that Adrian Hobbs has been promoted to Executive Vice President of its European Operations. Adrian currently oversees CRS’s most recent United Kingdom acquisition of Flex Recruitment.

“Adrian is a great business leader and will manage our aggressive growth plans in the European marketplace,” said Mark S. Levine, President and Chief Operating Officer of CRS. “After recently returning from several major acquisition meetings in Europe, it is apparent that Adrian possesses the experience in the European recruitment business that CRS requires in order to build our business organically and through acquisitions. We are looking forward to our continued expansion in Europe and building higher margin business to compliment CRS’s overall business strategy.”

About Corporate Resource Services, Inc.:

Corporate Resource Services, Inc. provides cloud-based enterprise applications and hosting services to PEO and staffing companies, as well as diversified staffing, recruiting, and consulting services. The Company offers trained employees in the areas of Insurance, Information Technology, Accounting, Legal, Engineering, Science, Healthcare, Life Sciences, Creative Services, Hospitality, Retail, General Business and Light Industrial work. The company’s blended staffing solutions are tailored to our customers’ needs and can include customized employee pre-training and testing, on-site facilities management, vendor management, risk assessment and management, market analyses and productivity/occupational engineering studies.

The Company operates 244 staffing and on-site facilities throughout the United States and the United Kingdom and it offers its services to a wide variety of clients in many industries, ranging from sole proprietorships to Fortune 1000 companies. To learn more, visit http://www.crsco.com

Forward Looking Statements:

Certain information contained in this press release, particularly information regarding completion of this offering, constitutes forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “seek,” “comfortable with,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

(NLNK) Letter Contract From Defense Threat Reduction Agency For Ebola Vaccine

(RIC) Consolidates 100% Ownership of Island Gold Mine

Jennifer Aitken, Investor Relations
RICHMONT MINES INC.
514 397-1410 ext. 101
jaitken@richmont-mines.com
Elaine Ellingham, Interim President & CEO
RICHMONT MINES INC.
514 397-1410 ext. 105
eellingham@richmont-mines.com
www.richmont-mines.com

(BSFT) Unified Communications Services to the Hospitality Industry With the Acquisition of SDD

Acquisition Opens New Vertical Market Opportunity for BroadSoft’s Service Provider Customers With a Fully Integrated Solution

(FLML) FDA Guidance to Unapproved Manufacturers of Neostigmine Methylsulfate

(GTIM) Announces Record Opening Sales of 2nd Bad Daddy’s Burger Bar

Good Times Restaurants Inc. (NASDAQ: GTIM), operator of Good Times Burgers & Frozen Custard, a regional quick service restaurant chain focused on fresh, high quality, all natural products and a licensee of Bad Daddy’s Burger Bar, a full service, upscale concept, today announced that it opened its second Bad Daddy’s restaurant in Colorado on July 28, 2014 and has achieved record sales volumes during its first week.

Boyd Hoback, President & CEO, said, “We are gratified to see our second store, which is in more of a traditional residential and retail trade area, come out of the blocks at record sales levels that has exceeded both our wildest expectations plus any of the highest system-wide Bad Daddy’s sales weeks ever by over 50% and was over twice the system’s average weekly sales. The customer feedback in the restaurant and on social media has been overwhelmingly positive and the rooftop patio and bar has been a huge hit with both families and the evening crowd. We changed up the beer menu to include unique, super-local microbrewery beers from Northglenn and Broomfield which has further grounded us as Northglenn’s own – in the words of customers ‘you are bringing cool to Northglenn.’ Our first store in Cherry Creek is more of an urban location and has had a little slower start than we had anticipated, which is exacerbated by disruption due to massive redevelopment and infrastructure work in the trade area – bad news in the short term but great news for the long term prospects for that location. We have our third Bad Daddy’s in Colorado scheduled to open this fall and we have several more in the pipeline for 2015, all of which are in upscale lifestyle shopping centers with solid upper-middle income demographics, which appears to be the sweet spot for the Bad Daddy’s concept.”

The Company said that it has identified ten initial trade areas along the front range of Colorado that it believes would support the development of a Bad Daddy’s restaurant and is evaluating other site opportunities in other markets. Hoback added, “Frank Scibelli, the founder of Bad Daddy’s, and his team in Charlotte are continuing to develop innovative menu items that can be executed in any market as well as ‘chef specials’ utilizing local ingredients that continue to make Bad Daddy’s a unique and compelling concept. Denver is a very competitive restaurant town and the sales at our second store are a testament to Bad Daddy’s consumer appeal.”

About Good Times Restaurants Inc.: Good Times Restaurants Inc. (NASDAQ: GTIM) operates Good Times Burgers & Frozen Custard, a regional chain of quick service restaurants located primarily in Colorado, in its wholly owned subsidiary, Good Times Drive Thru Inc. Good Times provides a menu of high quality all natural hamburgers, 100% all natural chicken tenderloins, fresh frozen custard, fresh cut fries, fresh lemonades and other unique offerings. Good Times currently operates and franchises 36 restaurants.

GTIM owns and operates Bad Daddy’s Burger Bar restaurants as a licensee through its wholly owned subsidiary, BD of Colorado LLC and plans to franchise Bad Daddy’s Burger Bar restaurants through its 48% ownership of Bad Daddy’s Franchise Development LLC. Bad Daddy’s Burger Bar is a full service, upscale, “small box” restaurant concept featuring a chef driven menu of gourmet signature burgers, chopped salads, appetizers and sandwiches with a full bar and a focus on a selection of craft microbrew beers in a high energy atmosphere that appeals to a broad consumer base.

Good Times Forward Looking Statements: This press release contains forward looking statements within the meaning of federal securities laws. The words “intend,” “may,” “believe,” “will,” “should,” “anticipate,” “expect,” “seek” and similar expressions are intended to identify forward looking statements. These statements involve known and unknown risks, which may cause the Company’s actual results to differ materially from results expressed or implied by the forward looking statements. These risks include such factors as the uncertain nature of current restaurant development plans and the ability to implement those plans, delays in developing and opening new restaurants because of weather, local permitting or other reasons, increased competition, cost increases or shortages in raw food products, and other matters discussed under the “Risk Factors” section of Good Times’ Annual Report on Form 10-K for the fiscal year ended September 30, 2013 filed with the SEC. Although Good Times may from time to time voluntarily update its forward looking statements, it disclaims any commitment to do so except as required by securities laws.

(CNIT) Announces Strategic Partnership with CITIC Securities

SHENZHEN, China, Aug. 4, 2014  — China Information Technology, Inc. (“CNIT” or the “Company”) (Nasdaq: CNIT), a leading provider of integrated internet-based platforms, products and services in China, today announced that the Company entered into a strategic partnership with CITIC Securities Co., Ltd. (“CITIC”) (Shanghai Stock Exchange: 600030).

As China’s largest securities broker by total asset and market share, CITIC is best known for its securities research and asset management in the Chinese capital market. Pursuant to the partnership agreement, CITIC will provide a variety of corporate financial services including mergers and acquisitions, pension management, and brokerage services on a needed basis. During CNIT’s strategic transition from traditional IT system integration to the cloud-based internet platform technology, CITIC will assist the Company in exploring various alternatives in China to enhance long-term shareholder value. In addition, CNIT and CITIC will collaborate to restructure CNIT’s traditional IT system integration business, which generates lower margin and higher receivables than the emerging cloud-based internet platform services.

With 271.4 billion RMB in total assets, CITIC had over 4 million brokerage clients in 2013. Managing over 504.9 billion RMB, CITIC also ranked No. 1 in asset management. CITIC is the parent company of CLSA Asia Pacific Markets. CITIC Securities is the securities arm of CITIC Group, which is one of China’s largest state-owned financial conglomerates.

Mr. Jiang Huai Lin, Chairman and Chief Executive Officer of the Company, commented, “With the launch of CNIT Cloud Platform powered by our proprietary Cloud-App-Terminal (CAT) technology, we are entering into a new period of innovation and potential growth. In addition to faster revenue growth, our goals are margin expansion and stronger cash-flow generation, which we believe will ultimately create long term value to our shareholders. The strategic partnership with CITIC is an important milestone for us. I believe CNIT shall benefit greatly from CITIC’s expertise in the Chinese capital market.”

About China Information Technology, Inc.

Headquartered in Shenzhen, China, China Information Technology, Inc., through its subsidiaries and other consolidated entities, provides CNIT Cloud Platform based on its proprietary Cloud-App-Terminal (CAT) model.  The Company’s cloud-based products include Cloud-based Education Platform (CEP), Information Distribution Platform (IDP), Online Ad Exchange Platform (OAEP), etc. The Company’s integrated hardware, software, and cloud-based services serve a variety of customers in the fields of government, education, healthcare, financial, commercial, communication and individual consumers. To learn more about the Company, please visit its corporate website at http://www.chinacnit.com .

Safe Harbor Statement

This press release includes certain statements that are not descriptions of historical facts, but are forward-looking statements in nature within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

For further information, please contact:

China Information Technology, Inc.
Tiffany Pan
Tel: +86 755 8370 4767
Email: IR@chinacnit.com
http://www.chinacnit.com

(SPCB) Selected for $22 Million in New Contracts

HERZLIYA, Israel, August 4, 2014  —

SuperCom Ltd. (NASDAQ: SPCB), a leading provider of Electronic Intelligence Solutions for National ID, Public Safety and Healthcare, today announced that it has been selected as the winning bidder for new contracts representing more than $22 million in size.

SuperCom will provide its various core and flexible electronic-ID solutions, with potential for additional follow-on orders in the future as is commonly realized with new customers. The majority of the revenue from the implementation of these contracts will be recognized within the next 9 months.

Commented Arie Trabelsi, President and CEO of SuperCom, “We are very pleased to have been selected as the winning bidders for these new significant contracts, clearly demonstrating our abilities and success in monetizing our vast and growing pipeline. We believe that these type of contracts are the initial stage in our building of a long-term relationship with new customers and will potentially bring us additional orders in the future. We continue to see fantastic growth in demand for our e-ID and M2M solutions globally, and we believe our success so far in 2014 only marks the beginning of strong and exciting international growth.”

About SuperCom

Since 1988, SuperCom has been a leading global provider of traditional and digital identity solutions, providing advanced safety, identification and security solutions to governments and organizations, both private and public, throughout the world. Through its proprietary e-Government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance and border control services, SuperCom has inspired governments and national agencies to design and issue secured Multi-ID documents and robust digital identity solutions to its citizens and visitors. SuperCom offers a unique all-in-one field-proven RFID & mobile technology and product suite, accompanied by advanced complementary services for various industries including healthcare and homecare, security and safety, community public safety, law enforcement, electronic monitoring, livestock monitoring, and building and access automation.

SuperCom’s website is http://www.supercom.com

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded or followed by or that otherwise include the words “believes”, “expects”, “anticipates”, “intends”, “projects”, “estimates”, “plans”, and similar expressions or future or conditional verbs such as “will”, “should”, “would”, “may” and “could” are generally forward-looking in nature and not historical facts. Forward-looking statements in this release also include statements about contracts and bid wins, business and economic trends. Investors should also consider the areas of risk described under the heading “Forward Looking Statements” and those factors captioned as “Risk Factors” in the Company’s periodic reports under the Securities Exchange Act of 1934, as amended, or in connection with any forward-looking statements that may be made by the Company. These statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements arising from the annual audit by management and the Company’s independent auditors. The Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release.

Investor Relations Contacts:
Ehud Helft & Kenny Green
GK Investor Relations
Tel: +1-646-201-9246
supercom@gkir.com

Company Contact:
Ordan Trabelsi, President North America
Tel: +1-212-675-4606
ordan@supercom.com

(CBMG) Announces Acquisition of Immune Cell Therapy Technology and U.S. Patent

PALO ALTO, Calif., Aug. 4, 2014  — Cellular Biomedicine Group Inc. (Nasdaq:CBMG) (the “Company”), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced reaching an agreement to acquire Agreen Biotech Co. Ltd. China (“AG”) and its founder’s U.S. patent for a total cash and equity consideration of $3.28 million in cash, the issuance of 753,522 shares of CBMG common stock and the issuance of 75,000 shares of CBMG restricted stock units.

The acquisition will include the Intellectual Properties (“IP”), assets and talents of this cancer-therapy-focused developmental stage company. The IP is comprised of T Cells Receptor (“TCR”) clonality analysis technology and T Central Memory Cell (“Tcm”) and Dendritic Cell (“DC”) preparation methodologies. The TCR clonality analysis technology is based on the use of the multiple sets of unique primers to amplify 22 regions of the TCR and thereby detect clonal expansions related to antigen stimulation of the immune system, which enables the assessment of tumor specific immunity with high accuracy and efficiency. Tcm cells are the subpopulation of T lymphocytes with key characteristics including high potency and long-term memory of specific immunity; and they are the key element of immunocellular fortification against tumors, infections and immune disorders. AG had approximately $1.1 million budding lab test kit sales and technical services revenue in 2013.

The Company expects to close the transaction and add 33 employees in the third quarter of 2014. Currently under China’s regulation, cancer patients treated with T-cell technology are entitled to medical insurance coverage in approximately ten provinces (equivalent to ten states in USA). According to the Administration of Clinical Application of Medical Technology, China has numerous AAA hospitals for in-patient cancer treatment and the number of cancer patients in China is growing rapidly. There are 3,120,000 new cancer patients in China annually, or 8,550 new patients per day. (Source: Annual Report of Chinese Cancer Statistics, April 2014)

“With these strategic acquisitions, we are delighted to add fortified U.S. and China IP of immune cell therapy preparation methodologies, and patient immunity assessment to our technology portfolio. The T Cell clonality analysis technology patent together with other know-how for immunity analysis, allows us to establish an immunoassay platform that is crucial for immunity evaluation of patients with immune disorders as well as cancerous diseases that are undergoing therapies. As cancer causes great emotional and economic burden across China and globally, we feel privileged to be actively involved in empowering hospitals’ existing and new immune cell cancer therapy development programs that may help relieve that burden,” said Dr. William (Wei) Cao, Chief Executive Officer of Cellular Biomedicine Group.

Professor Zhong Chen Kou, Co-Founder and Chief Scientist of AG, commented, “We are excited with this enlarged opportunity with CBMG to expand application of our cancer therapy-enabling technologies and look forward to initiating clinical trials with leading cancer hospitals, with the potential to not just extend life, but to improve quality of life.” Upon closing the transaction, Professor Kou will join the Company as Chief Scientist, Immunology.

“We believe that this enhanced cancer focus fits into our vision of providing solutions to significant unmet medical needs. As top hospitals in China adopt our newly acquired leading immune cell technology for immune cell cancer therapy development programs we expect rapid revenue growth,” stated Tony (Bizuo) Liu, Chief Financial Officer of Cellular Biomedicine Group.

About Cellular Biomedicine Group

Cellular Biomedicine Group, Inc. develops proprietary cell therapies for the treatment of certain degenerative diseases and cancers.  Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production lines, is designed, certified and managed according to U.S. standards.  To learn more about CBMG, please visit: www.cellbiomedgroup.com.

Forward-Looking Statements

Statements in this press release relating to plans, strategies, trends, specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as “may,” “will,” “expects,” “plans,” “intends,” “estimates,” “potential,” or “continue,” or similar terms or the negative of these terms. Although CBMG believes the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that future results, levels of activity, performance or achievements will be obtained. CBMG does not have any obligation to update these forward-looking statements other than as required by law.

CONTACT: Sarah Kelly
         Director of Corporate Communications, CBMG
         +1 650 566-5064
         sarah.kelly@cellbiomedgroup.com

         Vivian Chen
         Managing Director Investor Relations, Grayling
         +1 646 284-9427
         vivian.chen@grayling.com

(LMIA) Announces New Chief Operating Officer

Veteran Aerospace Executive Joseph DeMartino Joins Company

ST. LOUIS, Aug. 1, 2014  — LMI Aerospace, Inc. (Nasdaq:LMIA), a leading provider of design engineering services and supplier of structural assemblies, kits and components to the aerospace and defense markets, today announced that Joseph DeMartino has been named Chief Operating Officer, effective July 31.

“I am thrilled to announce the addition of Joe to our executive team,” said Dan Korte, President and Chief Executive Officer of LMI. “His tremendous leadership skills, senior management experience, technical and financial expertise coupled with a hands-on approach to problem solving is a perfect fit for the company.”

DeMartino will be responsible for the company’s day-to-day Aerostructures operations, for achievement of the company’s operational goals and application of operational excellence across the company. He will report directly to CEO Korte.

“I am extremely impressed with the leadership, professionalism and dedication of everyone who works at LMI,” DeMartino said. “I look forward to working with Dan, the board, the management team and the company’s customers, partners and employees as we build on LMI’s long history and achievements.”

DeMartino most recently worked as a consultant to the aerospace industry after serving in a series of executive positions with GKN Aerospace.  While based in St. Louis with GKN, he led the company’s largest North America subdivision in a changing landscape and interacted with top customers such as Boeing, Northrop Grumman, Gulfstream, Bell, Sikorsky, BAE Systems, Pratt & Whitney and Lockheed Martin. He began his career as an engineer in the Douglas Aircraft division of McDonnell Douglas Corporation.

“LMI is committed to growth and continuous improvement in our core and emergent business segments. I look forward to working with Joe as we build on the company’s strong values, meet our goals, exceed customer expectations and achieve operational excellence,” Korte added.

In connection with LMI’s offer of employment to DeMartino, and pursuant to his employment agreement dated July 31, 2014, DeMartino will be granted an inducement award pursuant to NASDAQ Listing Rule 5635(c)(4). The inducement award consists of 4,582 shares of restricted stock at a per share price of $13.095 with a value of $60,001 on the grant date, July 31, 2014. The stock shall vest on the three-year anniversary of the date of grant, subject to DeMartino’s continued employment on the vesting date. The award is being issued as an inducement material to DeMartino employment in accordance with NASDAQ Listing Rule 5635(c)(4).

About LMI:

LMI Aerospace, Inc. (“LMI”) is a leading supplier of structural assemblies, kits and components and provider of design engineering services to the aerospace and defense markets. Through its Aerostructures segment, the company primarily fabricates machines, finishes, integrates, assembles and kits machined and formed close tolerance aluminum, specialty alloy and composite components and higher level assemblies for use by the aerospace and defense industries. It manufactures more than 40,000 products for integration into a variety of aircraft platforms manufactured by leading original equipment manufacturers and Tier 1 aerospace suppliers. Through its Engineering Services segment, the company provides a complete range of design, engineering and program management services, supporting aircraft product lifecycles from conceptual design, analysis and certification through production support, fleet support and service life extensions via a complete turnkey engineering solution.

CONTACT: Renee Skonier
         Executive Legal Director
         636.916.2457

(ANIP) Acquires Vancocin® Capsules and Additional Vancomycin Assets from Shire

BAUDETTE, Minn., Aug. 1, 2014 — ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) today announced that it has acquired the US rights for Vancocin® 125 mg and 250 mg capsules from Shire plc, a global biopharmaceutical company.  In addition, ANI acquired from Shire approved ANDAs for the currently non-marketed products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm ($45 million in 2013 market value, per IMS Health) and vancomycin hydrochloride oral solution 250 mg and 500 mg.  ANI paid $11 million in cash for the rights to Vancocin® together with existing inventories on hand.  Following a transition period, ANI intends to launch Vancocin® capsules under its own label during the fourth quarter of 2014. The transaction is immediately accretive and sales of Vancocin® capsules are expected to generate approximately $5.4 million in revenues and $4 million in non-GAAP EBITDA annually.

Arthur S. Przybyl, ANI’s President and CEO stated, “We are excited to add Vancocin® capsules to our portfolio of mature brand products.  In addition, we will immediately begin exploring opportunities to launch both vancomycin injectable and vancomycin oral solution.  Year to date we have invested $23 million in two mature brand acquisitions that will contribute a combined $9.4 million in annual revenues and $8 million in annual non-GAAP EBITDA.  At the same time, we are continuing to advance our internal generic product development pipeline while selectively pursuing acquisitions and partnerships that augment those efforts.”

About ANI

ANI Pharmaceuticals, Inc. (the “Company” or “ANI”) is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company’s targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving extended release and combination products. For more information, please visit our website www.anipharmaceuticals.com.

Forward-Looking Statements

To the extent any statements made in this release deal with information that is not historical, these are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about price increases, the Company’s  future operations, products financial position, operating results and prospects , the Company’s pipeline or potential markets therefore, and other statements that are not historical in nature, particularly those that utilize terminology such as “anticipates,” “will,” “expects,” “plans,” “potential,” “future,” “believes,” “intends,” “continue,” other words of similar meaning, derivations of such words and the use of future dates.

Uncertainties and risks may cause the Company’s actual results to be materially different than those expressed in or implied by such forward-looking statements. Uncertainties and risks include, but are not limited to, the risk that the Company may face with respect to importing raw materials; increased competition; delays or failure in obtaining product approval from the U.S. Food and Drug Administration ; general business and economic conditions;  market trends; products development; regulatory and other approvals and marketing.

More detailed information on these and additional factors that could affect the Company’s actual results are described in the Company’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as its proxy statement. All forward-looking statements in this news release speak only as of the date of this news release and are based on the Company’s current beliefs, assumptions, and expectations. The Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

For more information about ANI, please contact:
Arthur S. Przybyl
(218) 634-3608
arthur.przybyl@anipharmaceuticals.com

(UBIC) Announces Opening of the UBIC North America Inc. Los Angeles Office

TOKYO, Aug. 1, 2014  — UBIC, Inc. (Nasdaq:UBIC) (TSE:2158), a leading provider of international litigation support and big-data analysis services, today announced that its UBIC North America Inc. subsidiary will open a new office in Los Angeles.

Since its establishment in Redwood City, California in December 2007, UBIC North America Inc. subsidiary has opened offices in Washing D.C. and New York to increase and improve services provided to Japanese and Asian companies operating in North America.

Responding to the demand from our existing Los Angeles-based customers to install a local office, The L.A. Branch Office will provide faster service and extended operations to the Los Angeles region, and will be used as a base to increase current customers’ satisfaction in the area and to develop new customers.

The new branch office’s address and contact information is as follows:

UBIC North America, Inc. L.A. Branch Office

6701 Center Ave, Suite 560, Los Angeles, CA 90045 USA

About UBIC

UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) is a leading provider of e-discovery and digital forensic services for Asia and the world. UBIC has extensive experience working with electronically stored information composed in Chinese, Japanese and Korean (CJK) languages and utilizes that expertise for clients involved in cross-border litigation, corporate investigations, intellectual property disputes and much more. At the forefront of e-discovery innovation, UBIC’s proprietary Lit i View^® platform is moving the industry from “fact discovery” to “future discovery” by allowing clients to analyze e-mail messages and digital communications found in big data to reveal patterns in human thought and behavior.

For more information about UBIC, contact us info@ubicna.com or visit http://www.ubicna.com

CONTACT: Sasha Hefler
         UBIC North America, Inc.
         Tel: (650) 868-2623
         sasha_hefler@ubicna.com

(FNHC) Announces Pricing of $40 Million Offering of Common Stock

SUNRISE, Fla., Aug. 1, 2014  — Federated National Holding Company (Nasdaq:FNHC) (the “Company”), a Florida-based provider of insurance, announced that it has priced an underwritten public offering of 2,051,283 shares of its common stock at a price to the public of $19.50 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters’ discounts and other estimated offering expenses payable by the Company, will be approximately $37.4 million. The Company has also granted the underwriters a 30-day option to purchase up to an additional 307,692 shares of common stock offered in the public offering to cover overallotments, if any.

The Company will use the net proceeds from the sale of the common stock for general working capital purposes, including as statutory capital in support of the Company’s growth and to sustain its capital levels after its investment in Monarch, once organized. The closing of the offering is subject to market and other conditions. The offering is expected to close on August 6, 2014.

Raymond James is serving as book-running manager, and William Blair and Janney Montgomery Scott are acting as co-managers.

The offering is being made pursuant to an effective shelf registration statement (File No. 333-195980) previously filed with the U.S. Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement related to the offering was filed with the SEC on July 29, 2014. A final prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the SEC on August 1, 2014 and will be available on its website at http://www.sec.gov. A copy of the prospectus relating to this offering may be obtained from Raymond James & Associates, Inc., 880 Carillon Parkway, St. Petersburg, Florida 33716, (800) 248-8863.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer of these securities will be solely by means of the prospectus included in the registration statement and the prospectus supplement that will be issued in connection with the offering.

About the Company

The Company is authorized to underwrite and/or place, through its wholly owned subsidiaries, homeowners’ multi-peril (“homeowners”), commercial general liability, federal flood, personal auto and various other lines of insurance in Florida and various other states. The Company markets and distributes its own and third-party insurers’ products and its other services through a network of independent agents. The Company also utilizes a select number of general agents for the same purpose.

Forward-Looking Statements/Safe Harbor Statement

Safe harbor statement under the Private Securities Litigation Reform Act of 1995:

Statements that are not historical fact are forward-looking statements that are subject to certain risks and uncertainties that could cause actual events and results to differ materially from those discussed herein. Without limiting the generality of the foregoing, words such as “anticipate,” “believe,” “budget,” “contemplate,” “continue,” “could,” “envision,” “estimate,” “expect,” “guidance,” “indicate,” “intend,” “may,” “might,” “plan,” “possibly,” “potential,” “predict,” “probably,” “pro-forma,” “project,” “seek,” “should,” “target,” or “will” or the negative thereof or other variations thereon and similar words or phrases or comparable terminology are intended to identify forward-looking statements.

Forward-looking statements might also include, but are not limited to, one or more of the following:

• Projections of revenues, income, earnings per share, dividends, capital structure or other financial items or measures;
• Descriptions of plans or objectives of management for future operations, insurance products, or services;
• Forecasts of future insurable events, economic performance, liquidity, need for funding and income; and
• Descriptions of assumptions or estimates underlying or relating to any of the foregoing.

The risks and uncertainties include, without limitation, risks and uncertainties related to estimates, assumptions and projections generally; the nature of the Company’s business; the adequacy of its reserves for loss and loss adjustment expense; claims experience; weather conditions (including the severity and frequency of storms, hurricanes, tornadoes and hail) and other catastrophic losses; reinsurance costs and the ability of reinsurers to indemnify the Company; raising additional capital and our potential failure to meet minimum capital and surplus requirements; potential assessments that support property and casualty insurance pools and associations; the effectiveness of internal financial controls; the effectiveness of our underwriting, pricing and related loss limitation methods; changes in loss trends; court decisions and trends in litigation; our potential failure to pay claims accurately; ability to obtain regulatory approval applications for requested rate increases, to underwrite in additional jurisdictions, or to organize a new property and casualty insurer in connection with our recently announced joint venture, and the timing thereof; the impact that this new insurer may have on our results of operations, once organized; inflation and other changes in economic conditions (including changes in interest rates and financial markets); pricing competition and other initiatives by competitors; legislative and regulatory developments; the outcome of litigation pending against the Company, and any settlement thereof; dependence on investment income and the composition of the Company’s investment portfolio; insurance agents; ratings by industry services; the reliability of our information technology systems; reliance on key personnel; acts of war and terrorist activities; and other matters described from time to time by the Company in releases and publications, and in periodic reports and other documents filed with the United States Securities and Exchange Commission.

In addition, investors should be aware that generally accepted accounting principles prescribe when a company may reserve for particular risks, including claims and litigation exposures. Accordingly, results for a given reporting period could be significantly affected if and when a reserve is established for a contingency. Reported results may therefore appear to be volatile in certain accounting periods.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. We do not undertake any obligation to update publicly or revise any forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

CONTACT: Michael H. Braun, CEO (954) 308-1322
         or Peter J. Prygelski, CFO (954) 308-1252
         Federated National Holding Company